<DOC>
	<DOCNO>NCT00004407</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine effect intravenous immunoglobulin recovery time patient proximal diabetic neuropathy . II . Determine whether rate response dose dependent patient .</brief_summary>
	<brief_title>Randomized Study Intravenous Immunoglobulin ( IVIg ) Patients With Subacute Proximal Diabetic Neuropathy</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control study . Patients randomize treatment low dose intravenous immunoglobulin ( IVIg ) , high dose IVIg , placebo . Patients must first complete baseline evaluation . Patients receive IVIg placebo day 1 , 2 , 3 , 5 , biweekly week 2-4 , weekly week 5-8 , every week week 9-12 . Patients assess 6 , 12 , 36 , 52 , 104 week . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnostically proven noninsulin dependent diabetes mellitus define follow criterion : Presence classic symptom , polyuria , polydipsia , ketonuria , rapid weight loss , together plasma glucose elevation Elevated fast glucose concentration one occasion Diagnostically proven proximal diabetic neuropathy follow symptom : Severe thigh , hip , leg pain Greater 20 % weight loss Progressive proximal weakness painful leg Weakness contralateral low limb Thoracic cervical root distribution Symmetric distal polyneuropathy autonomic neuropathy may mild absent Prior/Concurrent Therapy At least 6 month since prior immunosuppression plasma exchange No history prior renal transplant Patient Characteristics Age : 18 Performance status : Gait impairment least grade 2 Hematopoietic : Not specify Hepatic : Not specify Renal : Creatinine great 1.4 mg/dL ( woman ) Creatinine great 1.5 mg/dL ( men ) No history renal failure Cardiovascular : No history cardiac failure Neurologic : Normal nerve conduction study change compatible distal symmetric diabetic neuropathy diabetic lumbosacral radioplexus neuropathy Spinal fluid cell count le 5 cells/mm3 Normal cerebral spinal fluid cytology No structural spine disease No inherit neuropathy Other : Electromyographic evidence proximal low limb plexus OR Radicular denervation compatible proximal diabetic neuropathy No systemic disease malignancy Normal IgA level No chronic inflammatory demyelinate polyradiculoneuropathy ( CIDP ) No systemic amyloidosis No monoclonal gammopathy associate neuropathy No history allergy serum product No selective cervical root involvement without low limb weakness No evidence secondary diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>diabetic amyotrophy</keyword>
	<keyword>diabetic lumbosacral radiculoplexus neuropathy</keyword>
	<keyword>diabetic neuropathy</keyword>
	<keyword>diabetic proximal neuropathy</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>